EUVIMEDEUVIMED entdecken
Crossref

Molecular Mechanisms of Magnolol in Gastric Precancerous Lesions: A Computational and Experimental Study

Yuan Yang iD, Cuiqin Huang, Mengshu Li, Yuanxiangying Wen, Yiwei Jiang, Peiyuan Li, Xufeng Ning, Qilin Jiang, Lingshan Zhou iD, Weiwei Zhou, Bin Zeng

Chemistry & Biodiversity · 2025

DOI: 10.1002/cbdv.202402549 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Chemistry & Biodiversity, 2025. Verfasst von Yuan Yang und 10 weiteren Autor:innen. Beteiligte Einrichtung: Department of Gastroenterology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China. Hauptthemen laut MEDLINE: Lignans, Biphenyl Compounds, Stomach Neoplasms, Precancerous Conditions. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 37 Literaturangaben. Gefördert von: Natural Science Foundation of Gansu Province, Natural Science Foundation of Hunan Province, The Research Foundation of Education Bureau of Hunan Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The formation of gastric precancerous lesions (GPLs) has been identified as a critical step in tumorigenesis, and patients with GPLs have an increased risk of gastric cancer (GC). Magnolol is the primary biphenolic compound in Magnolia officinalis . It possesses various pharmacological properties, such as cardio‐ and neuroprotective properties, and inhibits tumor growth. However, its therapeutic effects on GPL treatment and the related mechanisms have not yet been studied. To address this, the mechanisms by which magnolol affects GPLs were elucidated via protein–chemical interaction prediction analysis, molecular docking, molecular dynamics (MD) simulation, and experimental verification. GPL‐related targets were obtained from the GeneCards database, whereas magnolol targets were obtained from the STITCH database. The two groups of targets were compared by constructing a Venn diagram, and potential key GPL‐related targets of magnolol were identified. Next, the interactions between the active compounds of magnolol and various epithelial–mesenchymal transition (EMT)‐related proteins were evaluated via molecular docking. The protein–compound complexes with the optimal binding affinity were analyzed via MD simulation. The efficacy of magnolol in the treatment of GPLs and the related mechanisms was further assessed using in vitro models. In this study, five core GPL‐related targets of magnolol were identified. Molecular docking revealed that magnolol and ERBB2 had the strongest binding affinity, suggesting that ERBB2 is a potentially important target for the treatment of GPLs. Similarly, MD simulations revealed a strong affinity between magnolol and ERBB2. Overall, this study showed that magnolol can inhibit the malignant behavior of precancerous lesions in GC cells. Magnolol exerts its pharmacological effects by acting on multiple targets. ERBB2 might be a potential target of magnolol in GPL treatment.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

LignansBiphenyl CompoundsStomach NeoplasmsPrecancerous ConditionsAntineoplastic Agents, PhytogenicHumansMolecular Docking SimulationMolecular Dynamics SimulationCell ProliferationEpithelial-Mesenchymal TransitionMolecular Structure

Stichwörter der Autor:innen

ERBB2gastric precancerous lesionsmagnololmolecular dockingmolecular dynamics simulation

Substanzen

magnololLignansBiphenyl CompoundsAntineoplastic Agents, Phytogenic

Autor:innen und Institutionen

  • Department of Gastroenterology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
  • Department of Pathology, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
  • Department of Hepatopancreatobiliary Surgery, The First Affiliated Hospital, Hengyang Medical School, University of South China, Hengyang, China.
  • Department of Geriatrics ward 2, the First Hospital of Lanzhou University, Lanzhou, China.

ORCID-Profile: Yuan Yang, Lingshan Zhou

Förderung

  • Natural Science Foundation of Gansu Province
  • Natural Science Foundation of Hunan Province
  • The Research Foundation of Education Bureau of Hunan Province
  • Scientific Research Fund Project of Hunan Provincial Health Commission

Zitieren

APA

Yang, Y., Huang, C., Li, M., Wen, Y., Jiang, Y., Li, P., Ning, X., Jiang, Q., Zhou, L., Zhou, W., & Zeng, B. (2025). Molecular Mechanisms of Magnolol in Gastric Precancerous Lesions: A Computational and Experimental Study. Chemistry & Biodiversity. https://doi.org/10.1002/cbdv.202402549

Vancouver

Yang Y, Huang C, Li M, Wen Y, Jiang Y, Li P, et al. Molecular Mechanisms of Magnolol in Gastric Precancerous Lesions: A Computational and Experimental Study. Chemistry & Biodiversity. 2025. doi:10.1002/cbdv.202402549

BibTeX
@article{Yang2025,
  author = {Yang, Yuan and Huang, Cuiqin and Li, Mengshu and Wen, Yuanxiangying and Jiang, Yiwei and Li, Peiyuan and Ning, Xufeng and Jiang, Qilin and Zhou, Lingshan and Zhou, Weiwei and Zeng, Bin},
  title = {Molecular Mechanisms of Magnolol in Gastric Precancerous Lesions: A Computational and Experimental Study},
  journal = {Chemistry & Biodiversity},
  year = {2025},
  doi = {10.1002/cbdv.202402549}
}
Kostenlos starten →